TempraMed TechnologiesFRA:9DY -14.16%1 Days Payable is 200.28 as of Mar. 2026, which is 19% below its 10-year median of 246.32. GuruFocus rates FRA:9DY with a GF Score™ of 1/100. The stock has 5 warning signs investors should review. Among 793 Medical Devices & Instruments companies, TempraMed Technologies ranks better than 92.81% on this metric.
The historical rank and industry rank for TempraMed Technologies's Days Payable or its related term are showing as below:
FRA:9DY'
s Days Payable Range Over the Past 10 Years
Min: 242.22 Med: 246.32 Max: 540.41
Current: 540.41
During the past 3 years, TempraMed Technologies's highest Days Payable was 540.41. The lowest was 242.22. And the median was 246.32.
FRA:9DY's Days Payable is ranked better than 92.81% of 793
companies
in the Medical Devices & Instruments industry
Industry Median: 67.87
vs FRA:9DY: 540.41
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, TempraMed Technologies's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TempraMed Technologies Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, TempraMed Technologies's Days Payable distribution charts can be found below:
* The bar in red indicates where TempraMed Technologies's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
TempraMed Technologies's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TempraMed Technologies (FRA:9DY) has a Days Payable of 200.28 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on TempraMed Technologies and its competitors. This is 19% below median its historical median of 246.32. Over the past decade, TempraMed Technologies' Days Payable has ranged from 242.22 to 540.41. According to the industry distribution chart, TempraMed Technologies ranks #57 out of 793 companies in the Medical Devices & Instruments industry, placing it in the top 7.2%.
Is TempraMed Technologies' Days Payable too high?
TempraMed Technologies' current Days Payable of 200.28 is 19% below median its 10-year median of 246.32. Over the past 10 years, this metric has ranged from a low of 242.22 to a high of 540.41. The Medical Devices & Instruments industry median Days Payable is 67.87. TempraMed Technologies' value of 200.28 is 195.1% above this industry median. Based on the distribution chart, TempraMed Technologies ranks #57 out of 793 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, TempraMed Technologies has a GF Score™ of 1/100, reflecting its overall financial health beyond just this single metric.
How does TempraMed Technologies' Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, TempraMed Technologies ranks #57 out of 793 companies for Days Payable. This places TempraMed Technologies in the top 7% of its industry — outperforming the majority of peers. The industry median Days Payable is 67.87. TempraMed Technologies' value of 200.28 is 195.1% above this benchmark. Historically, TempraMed Technologies' own Days Payable has ranged from 242.22 to 540.41 over the past decade. While the company's 10-year median is 246.32 vs. the industry median of 67.87, TempraMed Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 793 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TempraMed Technologies's current Days Payable of 200.28 is 195.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on TempraMed Technologies and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TempraMed Technologies's current Days Payable is 200.28, which is 19% below median its own 10-year median of 246.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TempraMed Technologies stock overvalued right now?
TempraMed Technologies (FRA:9DY) has a current Days Payable of 200.28. The current Days Payable is 200.28, which is 19% below median its 10-year median of 246.32 and 195.1% above the Medical Devices & Instruments industry median of 67.87. TempraMed Technologies' overall GF Score™ is 1/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For TempraMed Technologies (FRA:9DY), the current Days Payable is 200.28 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
TempraMed Technologies Ltd through its subsidiary, engaged in developing patent-protected technology designed to serve a broad range of medical and consumer products. TempraMed's primary focus is revolutionizing storage and management of injectable for temperature-sensitive medications. This inventive technology ensures adequate temperature storage conditions to medications without requiring power source or human intervention for years.
1GF Score
Get the complete analysis for FRA:9DY
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:9DY has been successfully added to your 
